World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
68
Citations
15937
World Ranking
2595
National Ranking
1238

R. Paul Johnson publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where R. Paul Johnson sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 160 publications — 20th percentile

20% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

R. Paul Johnson D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where R. Paul Johnson sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 68 D-Index — 49th percentile

49% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

R. Paul Johnson is affiliated with Emory University in the United States and focuses on research in medicine with particular emphasis on immunology and microbiology. Their work spans multiple subfields including infectious diseases, immunology, virology, neurology, and public health, environmental and occupational health.

Their research centers on topics such as COVID-19 clinical research studies, SARS-CoV-2 and COVID-19 research, immune cell function and interaction, HIV research and treatment, T-cell and B-cell immunology, interferon and immune responses, and the long-term effects of COVID-19.

Recent publications include the following:

  • Lymph node CXCR5+ NK cells associate with control of chronic SHIV infection (2022, JCI Insight)
  • Modulation of type I interferon responses potently inhibits SARS-CoV-2 replication and inflammation in rhesus macaques (2023, Science Immunology)
  • Modulation of type I interferon responses potently inhibits SARS-CoV-2 replication and inflammation in rhesus macaques (2022, bioRxiv, Cold Spring Harbor Laboratory)
  • Postnatal Zika virus infection is associated with persistent abnormalities in brain structure, function, and behavior in infant macaques (2021, UNC Libraries)

They have frequently collaborated with researchers including Gregory K. Tharp, Elise G. Viox, Timothy N. Hoang, Amit A. Upadhyay, and Rayhane Nchioua.

Key publication venues for their work include:

  • JCI Insight
  • Science Immunology
  • bioRxiv (Cold Spring Harbor Laboratory)
  • UNC Libraries

Best Publications

  • Gastrointestinal Tract as a Major Site of CD4+ T Cell Depletion and Viral Replication in SIV Infection

    Ronald S. Veazey;Mary Ann DeMaria;Laura V. Chalifoux;Daniel E. Shvetz

  • Dye efflux studies suggest that hematopoietic stem cells expressing low or undetectable levels of CD34 antigen exist in multiple species

    M. A. Goodell;M. Rosenzweig;Hyung Kim;D. F. Marks

  • Endogenous Bacterial Endophthalmitis: Report of a Ten-year Retrospective Study

    Annabelle A. Okada;R. Paul Johnson;W. Conrad Liles;Donald J. D'Amico

  • Neutralizing antibody-independent containment of immunodeficiency virus challenges by DNA priming and recombinant pox virus booster immunizations.

    H L Robinson;D C Montefiori;R P Johnson;K H Manson

  • Strong Cytotoxic T Cell and Weak Neutralizing Antibody Responses in a Subset of Persons with Stable Nonprogressing HIV Type 1 Infection

    Thomas Harrer;Ellen Harrer;Spyros A. Kalams;Tarek Elbeik

  • Suppression of human immunodeficiency virus type 1 replication by CD8+ cells: evidence for HLA class I-restricted triggering of cytolytic and noncytolytic mechanisms.

    O O Yang;S A Kalams;A Trocha;H Cao

  • Identification of Highly Attenuated Mutants of Simian Immunodeficiency Virus

    Ronald C. Desrosiers;Jeffrey D. Lifson;James S. Gibbs;Susan C. Czajak

  • Protection by Live, Attenuated Simian Immunodeficiency Virus against Heterologous Challenge

    Michael S. Wyand;Kelledy Manson;David C. Montefiori;Jeffrey D. Lifson

  • Inhibition of natural killer cell-mediated cytotoxicity by Kaposi's sarcoma-associated herpesvirus K5 protein.

    Satoshi Ishido;Joong-Kook Choi;Bok-Soo Lee;Chunyang Wang

  • A herpesvirus of rhesus monkeys related to the human Kaposi's sarcoma-associated herpesvirus.

    R C Desrosiers;V G Sasseville;S C Czajak;X Zhang

  • Efficient lysis of human immunodeficiency virus type 1-infected cells by cytotoxic T lymphocytes.

    O O Yang;S A Kalams;M Rosenzweig;A Trocha

  • Highly attenuated vaccine strains of simian immunodeficiency virus protect against vaginal challenge: inverse relationship of degree of protection with level of attenuation.

    R. Paul Johnson;Jeffrey D. Lifson;Susan C. Czajak;Kelly Stefano Cole

  • An Animal Model for Acute and Persistent Epstein-Barr Virus Infection

    Amir Moghaddam;Michael Rosenzweig;David Lee-Parritz;Bethany Annis

  • Diverse Host Responses and Outcomes following Simian Immunodeficiency Virus SIVmac239 Infection in Sooty Mangabeys and Rhesus Macaques

    A Kaur;R M Grant;R E Means;H McClure

  • Induction of vigorous cytotoxic T-lymphocyte responses by live attenuated simian immunodeficiency virus.

    R P Johnson;R L Glickman;J Q Yang;A Kaur

  • Lack of strong immune selection pressure by the immunodominant, HLA-A*0201-restricted cytotoxic T lymphocyte response in chronic human immunodeficiency virus-1 infection.

    C Brander;K E Hartman;A K Trocha;N G Jones

  • Induction of cytotoxic T lymphocyte and antibody responses to enhanced green fluorescent protein following transplantation of transduced CD34+ hematopoietic cells

    Michael Rosenzweig;Michelle Connole;Rhona Glickman;Soon-Pak Shinji Yue

  • Protective immunity induced by live attenuated simian immunodeficiency virus

    R Paul Johnson;Ronald C Desrosiers

  • Lysis of HIV-1-infected cells and inhibition of viral replication by universal receptor T cells

    O O Yang;A C Tran;S A Kalams;R P Johnson

  • Gene Regulatory Programs Conferring Phenotypic Identities to Human NK Cells.

    Patrick L. Collins;Marina Cella;Sofia I. Porter;Shasha Li

  • Effect of CD8+ Lymphocyte Depletion on Virus Containment after Simian Immunodeficiency Virus SIVmac251 Challenge of Live Attenuated SIVmac239Δ3-Vaccinated Rhesus Macaques

    Jörn E. Schmitz;R. Paul Johnson;Harold M. McClure;Kelledy H. Manson

  • Vaccine Protection against Simian Immunodeficiency Virus by Recombinant Strains of Herpes Simplex Virus

    Cynthia G. Murphy;William T. Lucas;Robert E. Means;Susan Czajak

Frequent Co-Authors

Ronald C. Desrosiers
Ronald C. Desrosiers University of Miami
Jeffrey D. Lifson
Jeffrey D. Lifson Leidos (United States)
Michael Piatak
Michael Piatak Leidos (United States)
Ashley T. Haase
Ashley T. Haase University of Minnesota
Keith G. Mansfield
Keith G. Mansfield Novartis (Switzerland)
Bruce D. Walker
Bruce D. Walker Harvard University
David C. Montefiori
David C. Montefiori Duke University
Mark B. Feinberg
Mark B. Feinberg International AIDS Vaccine Initiative
David I. Watkins
David I. Watkins George Washington University
John Sidney
John Sidney La Jolla Institute For Allergy & Immunology

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology, exploring related online degrees can open diverse career opportunities within healthcare and research. Many aspiring professionals consider pursuing a doctorate in nursing salary programs, which offer advanced practice knowledge and competitive compensation across various states.

Nurses looking to specialize can transition smoothly from an FNP (Family Nurse Practitioner) to an acute care role. Resources on how to effectively make this shift are invaluable, such as guides detailing the fnp to acnp journey. Understanding these pathways helps tailor your career toward specialized patient care in acute settings.

Accelerated options exist for those with a strong foundational background who want to become nurse practitioners quickly. Many prefer enrolling in an accelerated np program that balances flexibility with comprehensive clinical training.

For individuals without a nursing background but interested in healthcare roles related to immunology, there are several online nursing programs for non nurses. These pathways provide the necessary education to enter the nursing field and contribute meaningfully to immunology-focused clinical practice and research.

Best Scientists Citing R. Paul Johnson

Trending Scientists

Recently Published Articles